SETTLEMENT AGREEMENTSettlement Agreement • November 9th, 2010 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • California
This settlement agreement (“Settlement Agreement”) is entered into this 18th day of December 2003 (“Effective Date”) between Protein Design Labs, Inc., a corporation organized under the laws of the State of Delaware (hereafter “PDL”), and Genentech, Inc., a corporation organized under the laws of the State of Delaware (hereafter “Genentech”).
PDL BioPharma, Inc.Amendments to Product Licenses and Settlement Agreement • November 9th, 2010 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances)
AMENDED AND RESTATED PATENT LICENSING MASTER AGREEMENT (QUEEN PATENTS)Patent Licensing Master Agreement • November 9th, 2010 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • California
This AMENDED AND RESTATED PATENT LICENSING MASTER AGREEMENT (this “Agreement”) is entered into as of July 27, 2009 (the “Effective Date”) by and between PDL BioPharma, Inc., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 932 Southwood Boulevard, Incline Village, Nevada 89451 (hereinafter referred to as “PDL”), and Genentech, Inc., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 1 DNA Way, South San Francisco, California 94080 (hereinafter referred to as “GNE”).
